LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

Search

AstraZeneca PLC ADR

Closed

78.93 0.48

Overview

Share price change

24h

Current

Min

78.76

Max

79.22

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+8.77 upside

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

AstraZeneca PLC ADR Chart

Related News

25 kwi 2024, 09:42 UTC

Earnings

AstraZeneca Earnings, Sales Rise, Beating Forecasts -- Update

25 kwi 2024, 06:36 UTC

Earnings

AstraZeneca Earnings, Sales Rise, Beat Forecasts

20 cze 2024, 20:16 UTC

Top News

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- Update

20 cze 2024, 18:09 UTC

Top News

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- Update

20 cze 2024, 11:00 UTC

Top News

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- WSJ

10 cze 2024, 06:14 UTC

Market Talk

AstraZeneca Looks Well on Track to Reach 2030 Revenue Target -- Market Talk

7 cze 2024, 11:55 UTC

Top News

Germany's Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions - Interview

5 cze 2024, 06:00 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca PLC Acquisition of Fusion completed

5 cze 2024, 06:00 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca PLC Acquisition of Fusion completed

5 cze 2024, 04:45 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca Announced Acquisition on March 19

5 cze 2024, 04:43 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca Completes Acquisition of Fusion Pharmaceuticals

31 maj 2024, 20:08 UTC

Acquisitions, Mergers, Takeovers

Fusion Pharmaceuticals Shareholders to Get Deferred Payment in Form of Contingent Value Right of $3/Shr if Milestone Is Achieved >FUSN

31 maj 2024, 20:07 UTC

Acquisitions, Mergers, Takeovers

Fusion Pharmaceuticals Shareholders to Receive $21/Shr in Cash Upfront on Completion of Deal >FUSN

31 maj 2024, 20:06 UTC

Acquisitions, Mergers, Takeovers

Fusion Pharmaceuticals Receives Final Court Order Approving AstraZeneca Deal >FUSN

31 maj 2024, 13:24 UTC

Top News
Acquisitions, Mergers, Takeovers

AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030 -- Interview

31 maj 2024, 13:23 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca CEO: Company Doesn't Need Further Mergers and Acquisitions

31 maj 2024, 13:23 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca CEO: U.S. Inflation Reduction Act Could Hit Top Line By Around $500M

31 maj 2024, 13:23 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca's CEO Pascal Soriot Says He Has No Plans to Retire

21 maj 2024, 07:30 UTC

Market Talk

AstraZeneca's Revenue Target Signals Pipeline Momentum -- Market Talk

21 maj 2024, 06:17 UTC

Top News

AstraZeneca Targets $80B Revenue by 2030 Through Pipeline Expansion

25 kwi 2024, 16:43 UTC

Earnings

AstraZeneca, Anglo American, Deutsche Bank: European Stocks in Focus -- WSJ

25 kwi 2024, 15:28 UTC

Earnings

AstraZeneca, Anglo American, Deutsche Bank: European Stocks in Limelight -- WSJ

25 kwi 2024, 11:31 UTC

Earnings

AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags -- IBD

25 kwi 2024, 11:08 UTC

Market Talk
Earnings

AstraZeneca's Diversified Portfolio Shines -- Market Talk

25 kwi 2024, 10:15 UTC

Market Talk

AstraZeneca's Outlook Is Positive With Strong Focus on Investment -- Market Talk

25 kwi 2024, 07:52 UTC

Market Talk

AstraZeneca's Outperformance Let Down by Lack of Guidance -- Market Talk

25 kwi 2024, 06:00 UTC

Earnings

AstraZeneca PLC 1Q Pretax Pft $2.8B

25 kwi 2024, 06:00 UTC

Earnings

AstraZeneca PLC 1Q Adj EPS $7.00

25 kwi 2024, 06:00 UTC

Earnings

AstraZeneca PLC 1Q Rev $12.68B

25 kwi 2024, 06:00 UTC

Earnings

AstraZeneca PLC 1Q Oper Pft $3.12B

Peer Comparison

Price change

AstraZeneca PLC ADR Forecast

Price Target

By TipRanks

8.77% upside

12 Months Forecast

Average 85.8 USD  8.77%

High 97 USD

Low 81 USD

Based on 8 Wall Street analysts offering 12 month price targets forAstraZeneca PLC ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

78.38 / 79.64Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bullish Evidence